Dispenzieri, Angela http://orcid.org/0000-0001-8780-9512
Krishnan, Amrita
Arendt, Bonnie
Blackwell, Beth
Wallace, Paul K.
Dasari, Surendra
Vogl, Dan T. http://orcid.org/0000-0002-2935-2566
Efebera, Yvonne http://orcid.org/0000-0002-4163-8823
Fei, Mingwei
Geller, Nancy
Giralt, Sergio http://orcid.org/0000-0003-1944-5053
Hahn, Theresa http://orcid.org/0000-0002-3835-8855
Howard, Alan
Kohlhagen, Mindy
Landau, Heather http://orcid.org/0000-0002-3152-1189
Hari, Parameswaran http://orcid.org/0000-0002-8800-297X
Pasquini, Marcelo C.
Qazilbash, Muzaffar H. http://orcid.org/0000-0003-2876-2886
McCarthy, Philip
Shah, Nina
Vesole, David H.
Stadtmauer, Edward
Murray, David http://orcid.org/0000-0003-1720-335X
Article History
Received: 27 October 2021
Revised: 1 December 2021
Accepted: 8 December 2021
First Online: 10 February 2022
Competing interests
: AD: Research dollars: Alnylam, Celgene/BMS, Takeda, Pfizer; Consulting: Janssen, Oncopeptides and Regeneron. AK: Stock and Other Ownership Interests: Celgene (I), Kite Pharma (I); Consulting or Advisory Role: Celgene, Onyx, Janssen Oncology, Takeda, oncopeptides, and Regeneron; Speakers' Bureau: Celgene, Onyx, Janssen Oncology, Takeda; Research Funding: Janssen. BA: None. BB: Research dollars: Celgene (Inst), Takeda (inst). PKW: None. SD: Patent for mass spectrometry of blood immunoglobulins. DTV: Consulting or Advisory Role: Celgene, Amgen, Karyopharm Therapeutics, Teva, Janssen; Research Funding: Millennium (Inst), Acetylon Pharmaceuticals (Inst), GlaxoSmithKline (Inst), Calithera Biosciences (Inst), Constellation Pharmaceuticals (Inst); Travel, Accommodations, Expenses: Amgen. YE: Honoraria: Takeda; Speakers’ bureau: Takeda, Janssen, Akcea. MF: None. NG: None. SG: Honoraria: Celgene, Takeda, Amgen, Jazz Pharmaceuticals, Sanofi; Consulting or Advisory Role: Celgene, Takeda, Sanofi, Jazz Pharmaceuticals, Amgen, Janssen; Research Funding: Celgene (Inst), Celgene (Inst), Takeda, Miltenyi Biotec (Inst), Johnson & Johnson, Amgen; Travel, Accommodations, Expenses: Celgene, Sanofi, Amgen, Jazz Pharmaceuticals. TH: None. AH: None. MK: None. HL: Consulting or Advisory Role: Celgene, Takeda, Caelum Biosciences, Juno Therapeutics; Research Funding: Takeda. PH: Honoraria: Celgene, Takeda, Sanofi, Amben, Spectrum pharmaceuticals, Novartis; Consulting or Advisory role: Celgene, Sanofi, Spectrum Pharmaceuticals, Takeda, Bristol-Myer Squibb, Janssen, Amgen; Research funding: Millennium (Inst), Celgene (Inst), Onyx (inst), Spectrum Pharmaceuticals (Inst). MCP: Honoraria: Celgene; Consulting or Advisory Role: Pfizer, Medigene (Inst). MHQ: Consulting or Advisory Role: Amgen; Speakers' Bureau: Merck, Sanofi; Research Funding: Amgen, Tesaro. PM: Honoraria: Celgene, Karyopharm Therapeutics, Bristol-Myers Squibb, Sanofi, Janssen, The Binding Site; Consulting or Advisory Role: Celgene, Bristol-Myers Squibb, Karyopharm Therapeutics, Sanofi, Janssen, The Binding Site, Magenta; Research Funding: Celgene (Inst). NS: Research Funding: Celgene/BMS, Janssen, Bluebird Bio, Sutro Biopharma, Teneobio, Poseida, Nektar; Advisory role: GSK, Amgen, Indapta Therapeutics, Sanofi, CareDx, Kite, Karyopharm, Oncopeptides. DHV: Stock and Other Ownership Interests: Amgen, AbbVie, Biogen, Gilead Sciences, Johnson & Johnson, Eli Lilly, Novartis; Honoraria: Amgen, Takeda; Speakers' Bureau: Amgen, Celgene, Janssen Oncology, Takeda. ES: Consulting or Advirory role: Celgene, Takeda, Novartis, Teva, Janssen, Amgen, Sanofi. DM: Patent for mass spectrometry of blood immunoglobulins.